ProPhase Labs Announces Collaboration with G42 Healthcare
globenewswire.com
economics
2022-10-19 12:00:00

Companies target emerging markets across the globe and joint venture opportunitiesProPhase and G42 Healthcare to explore creation of advanced genomic sequencing facility in the USCompanies enter initial agreement aimed at improving genomic sequencing capabilities Garden City, NY, Oct. 19, 2022 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a growth-oriented and diversified diagnostics, genomics and biotech company, announced today that its wholly-owned subsidiary, ProPhase Precision Medicine Inc.
